{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:01:14Z","timestamp":1793257274736,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>It has been reported that the risk of second malignant neoplasms (SMNs) in long-term follow-up patients with heritable retinoblastoma (Rb) is significantly increased compared with patients with non-heritable Rb and the general population. In this study, we investigated the types, frequencies, clinical and pathologic features, potential risk factors, and outcomes of SMNs occurring in a large group of retinoblastoma patients that were diagnosed, treated, and followed up for a long time in our Pediatric Oncology unit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Our study comprehensively analyzed records of Rb patients followed up at Hacettepe University Pediatric Oncology Department over a 51-year period from January 1972 to January 2023. We determined the number, rate, and time of diagnosis of various SMN types and investigated potential risk factors that could lead to the development of SMNs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 491 patients were included in this study. Median age at the time of retinoblastoma diagnosis was 1.25 (range, 0.02 to 12.08) years. Of these cases, 313 (63.7%) were unilateral, 174 (35.4%) were bilateral, and 4 (0.9%) were trilateral Rb. Enucleation was performed in 348 (70.9%) cases. A total of 334 cases received systemic chemotherapy with different protocols. Intra-arterial chemotherapy (IAC) was administered in 101 (20.6%) patients. Radiotherapy was administered in 76 (15.5%) patients. After enucleation, 56 (11.4%) patients were followed up without further treatment. SMNs occurred in 13 (2.6%) of 491 patients. Among these, 9 (69.2%) patients were considered as having heritable Rb. Enucleation was performed in 10 cases. Only 1 patient received radiotherapy and 12 patients received systemic chemotherapy. Most common subtype of SMNs was osteosarcoma (n=7; 53.8%), followed by acute myeloid leukemia (AML) (n=3; 23.1%), acute lymphoblastic leukemia (ALL) (n=1; 7.7%), Wilms tumor (n=1; 7.7%), and colon adenocarcinoma (n=1; 7.7%). The median time from the diagnosis of Rb to the onset of SMN was 136 (range, 24 to 250) months. Among the patients that underwent IAC, no patient developed SMN. Of the 491 patients, 41 (8.3%) died and 450 are still alive. Of the 13 patients with SMN, 8 (61.5%) died and 5 are still alive. Five-year OS of our study group was 91% and it was significantly lower in patients with SMNs compared with those without SMNs (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In this study, overall survival (OS) was lower in patients with bilateral retinoblastoma compared with unilateral cases, and similarly reduced in patients who received radiotherapy compared with those who did not. In addition, the development of second malignant neoplasms (SMNs) was significantly higher in hereditary retinoblastoma patients than in non-hereditary cases. These findings highlight the importance of careful long-term monitoring and tailored follow-up strategies in patients at increased risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000003039","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:00:10Z","timestamp":1745352010000},"page":"e161-e167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8094-2898","authenticated-orcid":false,"given":"Eren","family":"M\u00fcngen","sequence":"first","affiliation":[{"name":"Pediatric Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9370-6173","authenticated-orcid":false,"given":"\u0130rem","family":"Ko\u00e7","sequence":"additional","affiliation":[{"name":"Ophthalmology, Ocular Oncology Service, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-4740","authenticated-orcid":false,"given":"Hayyam","family":"Kiratli","sequence":"additional","affiliation":[{"name":"Ophthalmology, Ocular Oncology Service, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-1476","authenticated-orcid":false,"given":"Ali","family":"Varan","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"R1-20250623","doi-asserted-by":"crossref","first-page":"e2022126","DOI":"10.1001\/jamanetworkopen.2020.22126","article-title":"Incidence and mortality of second primary cancers in Danish patients with retinoblastoma, 1943-2013","volume":"3","author":"Gregersen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R2-20250623","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/bjc.2013.228","article-title":"Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004","volume":"108","author":"MacCarthy","year":"2013","journal-title":"Br J Cancer"},{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41416-020-01248-y","article-title":"Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors","volume":"124","author":"Schonfeld","year":"2021","journal-title":"Br J Cancer"},{"key":"R4-20250623","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/pbc.24714","article-title":"Subsequent malignancies and their effect on survival in patients with retinoblastoma","volume":"61","author":"Shinohara","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250623","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2013.54.7844","article-title":"Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy","volume":"32","author":"Wong","year":"2014","journal-title":"J Clin Oncol"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jjco\/hyq201","article-title":"Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan","volume":"41","author":"Araki","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/bjophthalmol-2014-306206","article-title":"Improving survival of retinoblastoma in Uganda","volume":"99","author":"Waddell","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R8-20250623","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/cancers13061200","article-title":"Subsequent malignant neoplasms in retinoblastoma survivors","volume":"13","author":"Fabius","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/djn394","article-title":"Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up","volume":"100","author":"Marees","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djh058","article-title":"Lifetime risks of common cancers among retinoblastoma survivors","volume":"96","author":"Fletcher","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","article-title":"Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up","volume":"23","author":"Kleinerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-20250623","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/djp046","article-title":"Cause-specific mortality in long-term survivors of retinoblastoma","volume":"101","author":"Yu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R14-20250623","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jnci\/85.14.1121","article-title":"Mortality from second tumors among long-term survivors of retinoblastoma","volume":"85","author":"Eng","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R15-20250623","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.1997.03550150066037","article-title":"Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"},{"key":"R16-20250623","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/djk002","article-title":"Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma","volume":"99","author":"Kleinerman","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R17-20250623","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.2011.37.0239","article-title":"Variation of second cancer risk by family history of retinoblastoma among long-term survivors","volume":"30","author":"Kleinerman","year":"2012","journal-title":"J Clin Oncol"},{"key":"R18-20250623","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejca.2009.05.011","article-title":"Cancer mortality in long-term survivors of retinoblastoma","volume":"45","author":"Marees","year":"2009","journal-title":"Eur J Cancer"},{"key":"R19-20250623","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V","article-title":"Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994","volume":"67","author":"Moll","year":"1996","journal-title":"Int J Cancer"},{"key":"R20-20250623","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bjo.81.7.559","article-title":"Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995","volume":"81","author":"Moll","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R21-20250623","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.ejca.2010.03.029","article-title":"Risk of third malignancies and death after a second malignancy in retinoblastoma survivors","volume":"46","author":"Marees","year":"2010","journal-title":"Eur J Cancer"},{"key":"R22-20250623","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/jnci\/djy227","article-title":"Patterns of cause-specific mortality among 2053 survivors of retinoblastoma, 1914-2016","volume":"111","author":"Kleinerman","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"R23-20250623","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(01)00713-8","article-title":"Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma","volume":"108","author":"Abramson","year":"2001","journal-title":"Ophthalmology"},{"key":"R24-20250623","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","article-title":"Trilateral retinoblastoma: a systematic review and meta-analysis","volume":"15","author":"de Jong","year":"2014","journal-title":"Lancet Oncol"},{"key":"R25-20250623","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ophtha.2020.05.024","article-title":"Recommendations for long-term follow-up of adults with heritable retinoblastoma","volume":"127","author":"Tonorezos","year":"2020","journal-title":"Ophthalmology"},{"key":"R26-20250623","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archophthalmol.2010.126","article-title":"Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type","volume":"128","author":"Woo","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R27-20250623","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/pbc.25576","article-title":"Pediatric second primary malignancies after retinoblastoma treatment","volume":"62","author":"Temming","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R28-20250623","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM198709033171002","article-title":"Bone sarcomas linked to radiotherapy and chemotherapy in children","volume":"317","author":"Tucker","year":"1987","journal-title":"N Engl J Med"},{"key":"R29-20250623","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1200\/JCO.2015.65.4012","article-title":"How eye-preserving therapy affects long-term overall survival in heritable retinoblastoma survivors","volume":"34","author":"Temming","year":"2016","journal-title":"J Clin Oncol"},{"key":"R30-20250623","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pbc.23278","article-title":"Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma","volume":"59","author":"Turaka","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20250623","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"R32-20250623","doi-asserted-by":"crossref","first-page":"1406215","DOI":"10.3389\/fmed.2024.1406215","article-title":"Mutational analysis of the RB1 gene in patients with unilateral retinoblastoma","volume":"11","author":"Yousef","year":"2024","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:01:01Z","timestamp":1750690861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003039","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"2024-09-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}